封面
市场调查报告书
商品编码
1411616

避孕药市场:依产品、年龄层、给药途径、分布 - 全球预测 2024-2030

Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年避孕药具市场规模为195.3亿美元,预计2024年将达207.6亿美元,2030年将达302.7亿美元,复合年增长率为6.46%。

全球避孕药市场

主要市场统计
基准年[2023] 195.3亿美元
预测年份 [2024] 207.6亿美元
预测年份 [2030] 302.7亿美元
复合年增长率(%) 6.46%
避孕药市场-IMG1

避孕药是含有合成荷尔蒙的口服药物,旨在调节女性的月经週期并防止意外怀孕。这些药物的主要作用是抑制排卵、改变子宫颈黏液以限制精子的通过,以及改变子宫内膜以最大限度地减少受精卵的着床。不同年龄层和文化对计划生育方法的认识不断提高,对安全有效避孕药具的需求也随之增加。然而,由于市场上有替代避孕方法和不合格产品,消费者取得避孕药具的机会受到限制。然而,开拓具有更高功效和更少副作用的新配方预计将为避孕市场提供潜在机会。

区域洞察

在美洲,由于广泛的宣传宣传活动、政府支持以及製造商在新避孕药配方方面的技术进步,避孕药市场正在扩大。根据美国国家医学图书馆 (NLM) 的数据,目前美国15 岁至 44 岁的女性中约有 25% 选择避孕药作为避孕方法。在欧洲地区,促进计划生育教育和负担能力的公共卫生计划使避孕药具的使用变得流行。亚太地区面临中国和印度等人口稠密的经济体,创造了对负担得起的避孕药具的需求并呈现出市场成长前景。此外,许多新兴和开发中国家正在透过推出计划生育教育和宣传计划为市场创造机会。

FPNV定位矩阵

FPNV定位矩阵对于评估避孕市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以对避孕市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略,从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解:

1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。

3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1-避孕药市场的市场规模和预测是多少?

2-避孕药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?

3-避孕市场的技术趋势和法律规范是什么?

4-避孕药市场主要供应商的市场占有率是多少?

5-进入避孕药具市场的适当型态或策略手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加避孕药具的使用,防止意外怀孕
      • 提高性行为感染传染病 (STD) 的盛行率和认识
      • 政府支持促进避孕药具的使用
    • 抑制因素
      • 避孕药对健康的不良影响
    • 机会
      • 避孕药配方和包装的持续进步
      • 线上管道提供避孕药具
    • 任务
      • 有关锭剂使用和产品行销问题的安全和社会问题
  • 市场区隔分析
    • 产品:计划生育联合药物的大量采用
    • 年龄层:15-24岁年龄层避孕药具使用率较高。
    • 经销:避孕药具线上通路的演变
    • 管理途径:依易用性区分使用者对口服避孕药的偏好
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 避孕药市场:副产品

  • 组合药丸
  • 延续/延长药丸
  • 黄体酮锭剂

第七章 避孕药市场:依年龄组别

  • 15-24
  • 25-34
  • 35-44
  • 45岁以上

第八章 避孕药市场:给药给药途径

  • 口服
  • 视觉的

第九章 避孕药市场分布

  • 离线
  • 在线的

第十章美洲避孕药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太避孕市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲避孕市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析:主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强

第14章竞争产品组合

  • 主要公司简介
    • AbbVie Inc.
    • Afaxys Pharma, LLC
    • Amneal Pharmaceuticals, Inc.
    • Apotex Inc.
    • Aurobindo Pharma Limited
    • Bayer AG
    • Bionpharma Inc.
    • Cipla Limited
    • Combe Incorporated
    • Gedeon Richter PLC
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson Services, Inc.
    • Julie Product Inc.
    • Lupin Limited
    • Mankind Pharma Ltd.
    • Mayne Pharma Group Limited
    • Merck & Co., Inc.
    • Northstar Rx LLC
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Sun Pharmaceutical Industries Limited
    • Syzygy Healthcare Solutions, LLC
    • Teva Pharmaceuticals
    • Viatris Inc.
    • Xiromed, LLC
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-A579C4315A26

[182 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.

Global Contraceptive Pills Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.53 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 30.27 billion
CAGR (%) 6.46%
Contraceptive Pills Market - IMG1

Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.

Regional Insights

In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Combination Pill
    • Continuous/Extended Pill
    • Progesterone Pill
  • Age Group
    • 15-24
    • 25-34
    • 35-44
    • 45 and Above
  • Route of Administration
    • Oral
    • Viginal
  • Distribution
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contraceptive Pills Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Pills Market?

3. What are the technology trends and regulatory frameworks in the Contraceptive Pills Market?

4. What is the market share of the leading vendors in the Contraceptive Pills Market?

5. Which modes and strategic moves are suitable for entering the Contraceptive Pills Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Contraceptive Pills Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies
      • 5.1.1.2. Growing prevalence and awareness toward sexually transmitted diseases (STDs)
      • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
      • 5.1.3.2. Availability of contraceptive pills on online channels
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant adoption of combination pills for family planning
    • 5.2.2. Age Group: High usage of contraceptive pills in the age group 15 to 24
    • 5.2.3. Distribution: Evolving online distribution channels for contraceptive pills
    • 5.2.4. Route of Administration: User preferences for oral contraceptive pills owing to ease of use
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Contraceptive Pills Market, by Product

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Contraceptive Pills Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Viginal

9. Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. FDA approves first nonprescription daily oral contraceptive
      • 13.3.2.2. Gedeon Richter announces availability of oral contraception Drovelis

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Afaxys Pharma, LLC
    • 14.1.3. Amneal Pharmaceuticals, Inc.
    • 14.1.4. Apotex Inc.
    • 14.1.5. Aurobindo Pharma Limited
    • 14.1.6. Bayer AG
    • 14.1.7. Bionpharma Inc.
    • 14.1.8. Cipla Limited
    • 14.1.9. Combe Incorporated
    • 14.1.10. Gedeon Richter PLC
    • 14.1.11. Glenmark Pharmaceuticals Limited
    • 14.1.12. Johnson & Johnson Services, Inc.
    • 14.1.13. Julie Product Inc.
    • 14.1.14. Lupin Limited
    • 14.1.15. Mankind Pharma Ltd.
    • 14.1.16. Mayne Pharma Group Limited
    • 14.1.17. Merck & Co., Inc.
    • 14.1.18. Northstar Rx LLC
    • 14.1.19. Perrigo Company plc
    • 14.1.20. Pfizer Inc.
    • 14.1.21. Piramal Enterprises Ltd.
    • 14.1.22. Sun Pharmaceutical Industries Limited
    • 14.1.23. Syzygy Healthcare Solutions, LLC
    • 14.1.24. Teva Pharmaceuticals
    • 14.1.25. Viatris Inc.
    • 14.1.26. Xiromed, LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
  • FIGURE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. CONTRACEPTIVE PILLS MARKET LICENSE & PRICING